The perils of a narrow stock market rally (and the opportunities)

The 'Magnificent 7' have contributed half of the performance in global equities this calendar year and as much as 70% of the S&P’s rally.
Alison Savas

Antipodes

We’ve had the FAANGs, the MAGMA stocks, and now it’s the so-called Magnificent 7 – Alphabet, Amazon, Apple, Meta, Microsoft, Nvidia and Tesla. These seven stocks have contributed half of the performance in global equities this calendar year and as much as 70% of the S&P’s rally, taking the latter to just 5% from its all-time highs in the previous quarter.

While it does feel like the growth trade is back, the equity rally has become increasingly unbalanced and such narrow performance doesn’t necessarily indicate animal spirits are alive and well.

We’re not seeing a return to the broad-based growth-at-any price duration bubble we saw in 2021. Real rates are 1.6% and rising, not 0% or negative real rates seen from 2020 to 2022 which supported the duration bubble.

But we’re also not seeing outperformance of the more traditional defensive sectors either.

Instead, we’re seeing performance of a very narrow subset of stocks that are perceived to be both defensive and have structural growth prospects.

There’s a continuum of outcomes between a hard landing (recession) and a soft landing.

At the margin, it does looks like the market is tilted to the soft-landing scenario and pricing in an improvement in the growth/inflation mix. That is, the market is saying growth will remain relatively resilient while inflation recedes, and that the Fed will ultimately be able to gently ease off the brakes as opposed to slamming them on to avoid a recession. 

What's being priced in?

US equities are priced at 23x the prior 12-month earnings, which is 10% more expensive than the average multiple over the last 10 years. Additionally, consensus forecasts assume FY23 earnings will be flat on a year-on-year basis, despite the tightening that’s already in place, and consensus is factoring in a 14% increase in earnings in 2024.

The juxtaposition is we’re just beginning to see the lagged effects of monetary tightening on credit growth, and the lead indicators continue to point to a weaker growth outlook.

Money supply is contracting faster than ever due to Quantitative Tightening and tighter lending standards, and the capital position of banks remains under pressure.

The lags to monetary policy range between 12 – 18 months so the full impact is yet to be felt. This will be challenging for growth. The service sector, which has been supporting economic activity globally, is losing momentum, and manufacturing, construction, house prices and world trade still remain under pressure.

If the leading indicators are correct, we could see a 15% drawdown in US earnings which would see US equities reach 26x earnings. This is a substantial premium to its own history and the rest of the world which has already gone through an earnings downgrade cycle.

Valuations in Europe and China are closer to 13-14x earnings.

Hence, the margin for error in US equities is high. 

We think activity will continue to slow, and there’s a risk that the Fed overtightens or takes too long to pause as it focuses on wage inflation.

Macro
A "vanishingly small" chance of avoiding recession

Where could the positive surprises come from?

Despite the data, the most anticipated recession in the West is yet to arrive.

Non-residential investment has remained more resilient than the manufacturing sector. This could be related to policies around decarbonisation and supply chain security like the Inflation Reduction Act and the CHIPs Act in the US.

If non-residential construction growth proves to be more structural it will provide some support to economic activity, and we are tracking this closely.

Upside could also come from more policy support, with China the likely candidate. While the absence of a co-ordinated policy response to date has surprised us particularly given the Chinese economy is facing deflation, a lack of improvement in the domestic economy or further weakening in the global economy should see policy makers push towards more stimulus given meaningful firepower to act and a risk of social instability if the labour market fails to recover further.

Youth unemployment is 20%. Additional stimulus won’t just support a domestic recovery, the size of the Chinese economy means it can also change the global economic outlook even without the big bang stimulus of the past.

Portfolio positioning amid the narrow rally

Western recession remains our investment team's base case. We’re still relatively defensively positioned with a focus on containing the global portfolios’ exposure to cyclicality in preference for attractively priced growth and quality, while maintaining our tilt to value.

If the leading indicators evolve to suggest the Fed can engineer a soft landing, by-pass recession altogether culminating in a dovish pivot, or if there is a broadening out of performance in the equity market, it will become more appropriate to lean into our cyclical exposures e.g. beneficiaries of policies that address climate change and supply chain security (on/near-shoring). While these investment cycles may already be underway we are still in the early stage of this secular shift and many of these businesses are not efficiently priced, particularly outside of the US.

Antipodes portfolio positioning and a number of our key portfolio holdings, including Heineken (AMS: HEIA), Amazon (NASDAQ: AMZN) and TotalEnergies SE (EPA: TTE) is discussed in our latest podcast episode. 

You can listen here or subscribe on Apple, Google or Spotify  

Managed Fund
Antipodes Global Fund – Long
Global Shares
Managed Fund
Antipodes Global Fund
Global Shares
ETF
Antipodes Global Shares (Quoted Managed Fund) (AGX1)
Global Shares
........
This communication was prepared by Antipodes Partners Limited (ABN 29 602 042 035, AFSL 481 580) (Antipodes). Antipodes believes the information contained in this communication is based on reliable information, no warranty is given as to its accuracy and persons relying on this information do so at their own risk. This communication is for general information only and was prepared for multiple distribution and does not take account of the specific investment objectives of individual recipients and it may not be appropriate in all circumstances. Persons relying on this information should do so in light of their specific investment objectives and financial situations. Any person considering action on the basis of this communication must seek individual advice relevant to their particular circumstances and investment objectives. Subject to any liability which cannot be excluded under the relevant laws, Antipodes disclaim all liability to any person relying on the information contained on this website in respect of any loss or damage (including consequential loss or damage), however caused, which may be suffered or arise directly or indirectly in respect of such information. Any opinions or forecasts reflect the judgment and assumptions of Antipodes on the basis of information at the date of publication and may later change without notice. Any projections are estimates only and may not be realised in the future. Information on this website is not intended as a securities recommendation or statement of opinion intended to influence a person or persons in making a decision in relation to investment. Unauthorised use, copying, distribution, replication, posting, transmitting, publication, display, or reproduction in whole or in part of the information contained on the website is prohibited without obtaining prior written permission from Antipodes. Pinnacle Fund Services Limited ABN 29 082 494 362 AFSL 238371 is the product issuer of funds managed by Antipodes. Any potential investor should consider the relevant Product Disclosure Statement available at www.antipodesonespartners.com when deciding whether to acquire, or continue to hold units in a fund. The issuer is not licensed to provide financial product advice. Please consult your financial adviser before making a decision. Past performance is not a reliable indicator of future performance.

1 stock mentioned

1 contributor mentioned

Alison Savas
Investment Director
Antipodes

In almost two decades of investing in equities based in Sydney and Singapore, Alison has worked through various market cycles and navigated major market events. Alison is an investment director at Antipodes and a member of the senior investment...

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.

Comments

Sign In or Join Free to comment